A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in japan

Yoshiaki Ikeda, Takayoshi Mamiya, Hideki Nishiyama, Shiho Narusawa, Takenao Koseki, Akihiro Mouri, Toshitaka Nabeshima

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Some drug management systems have been established in Japanese hospitals to reduce medical costs and regulate drug usage. Among the many available prescription drugs, antimicrobials should be given special attention because their inappropriate use often leads to sudden outbreaks of resistant bacteria. As drug specialists, pharmacists should monitor the use of all drugs, particularly antimicrobials. Carbapenems are a class of broad-spectrum antimicrobials that are widely used to treat infections worldwide. However, their inappropriate use has led to an increase in the incidence of drug-resistant bacteria and consequently, medical costs, at hospitals. To reduce inappropriate use and drug resistance, we have established a permission system to control the use of carbapenems at the Japanese Red Cross Nagoya Daiichi Hospital. In this study, we retrospectively evaluated the applicability of the new permission system compared to that of the notification system and the non control system for 14 months each. The two management systems were able to maintain total antibiotic use density and control the outbreak of drug-resistant bacteria (P. aeruginosa, E. coli, and K. pneumoniae). The number of carbapenem prescriptions was decreased dramatically when this permission system was enforced. Compared to the non control system, the cost of antimicrobials was reduced by $757,470 for the 14-month study period using the permission system. These results suggest that our system to control the use of antimicrobials can efficiently suppress the incidence of drug-resistant bacteria and medical costs at hospitals.

Original languageEnglish
Pages (from-to)93-104
Number of pages12
JournalNagoya Journal of Medical Science
Volume74
Issue number1-2
Publication statusPublished - 01-12-2012
Externally publishedYes

Fingerprint

Carbapenems
Drug Costs
General Hospitals
Japan
Bacteria
Incidence
Pharmaceutical Preparations
Hospital Costs
Disease Outbreaks
Red Cross
Prescription Drugs
Cost Control
Drug and Narcotic Control
Pharmacists
Drug Resistance
Prescriptions
Pneumonia
Escherichia coli
Anti-Bacterial Agents
Infection

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{095ea46f266f4d1d83c946116dc1058f,
title = "A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in japan",
abstract = "Some drug management systems have been established in Japanese hospitals to reduce medical costs and regulate drug usage. Among the many available prescription drugs, antimicrobials should be given special attention because their inappropriate use often leads to sudden outbreaks of resistant bacteria. As drug specialists, pharmacists should monitor the use of all drugs, particularly antimicrobials. Carbapenems are a class of broad-spectrum antimicrobials that are widely used to treat infections worldwide. However, their inappropriate use has led to an increase in the incidence of drug-resistant bacteria and consequently, medical costs, at hospitals. To reduce inappropriate use and drug resistance, we have established a permission system to control the use of carbapenems at the Japanese Red Cross Nagoya Daiichi Hospital. In this study, we retrospectively evaluated the applicability of the new permission system compared to that of the notification system and the non control system for 14 months each. The two management systems were able to maintain total antibiotic use density and control the outbreak of drug-resistant bacteria (P. aeruginosa, E. coli, and K. pneumoniae). The number of carbapenem prescriptions was decreased dramatically when this permission system was enforced. Compared to the non control system, the cost of antimicrobials was reduced by $757,470 for the 14-month study period using the permission system. These results suggest that our system to control the use of antimicrobials can efficiently suppress the incidence of drug-resistant bacteria and medical costs at hospitals.",
author = "Yoshiaki Ikeda and Takayoshi Mamiya and Hideki Nishiyama and Shiho Narusawa and Takenao Koseki and Akihiro Mouri and Toshitaka Nabeshima",
year = "2012",
month = "12",
day = "1",
language = "English",
volume = "74",
pages = "93--104",
journal = "Nagoya Journal of Medical Science",
issn = "0027-7622",
publisher = "Nagoya University, School of Medicine",
number = "1-2",

}

A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in japan. / Ikeda, Yoshiaki; Mamiya, Takayoshi; Nishiyama, Hideki; Narusawa, Shiho; Koseki, Takenao; Mouri, Akihiro; Nabeshima, Toshitaka.

In: Nagoya Journal of Medical Science, Vol. 74, No. 1-2, 01.12.2012, p. 93-104.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in japan

AU - Ikeda, Yoshiaki

AU - Mamiya, Takayoshi

AU - Nishiyama, Hideki

AU - Narusawa, Shiho

AU - Koseki, Takenao

AU - Mouri, Akihiro

AU - Nabeshima, Toshitaka

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Some drug management systems have been established in Japanese hospitals to reduce medical costs and regulate drug usage. Among the many available prescription drugs, antimicrobials should be given special attention because their inappropriate use often leads to sudden outbreaks of resistant bacteria. As drug specialists, pharmacists should monitor the use of all drugs, particularly antimicrobials. Carbapenems are a class of broad-spectrum antimicrobials that are widely used to treat infections worldwide. However, their inappropriate use has led to an increase in the incidence of drug-resistant bacteria and consequently, medical costs, at hospitals. To reduce inappropriate use and drug resistance, we have established a permission system to control the use of carbapenems at the Japanese Red Cross Nagoya Daiichi Hospital. In this study, we retrospectively evaluated the applicability of the new permission system compared to that of the notification system and the non control system for 14 months each. The two management systems were able to maintain total antibiotic use density and control the outbreak of drug-resistant bacteria (P. aeruginosa, E. coli, and K. pneumoniae). The number of carbapenem prescriptions was decreased dramatically when this permission system was enforced. Compared to the non control system, the cost of antimicrobials was reduced by $757,470 for the 14-month study period using the permission system. These results suggest that our system to control the use of antimicrobials can efficiently suppress the incidence of drug-resistant bacteria and medical costs at hospitals.

AB - Some drug management systems have been established in Japanese hospitals to reduce medical costs and regulate drug usage. Among the many available prescription drugs, antimicrobials should be given special attention because their inappropriate use often leads to sudden outbreaks of resistant bacteria. As drug specialists, pharmacists should monitor the use of all drugs, particularly antimicrobials. Carbapenems are a class of broad-spectrum antimicrobials that are widely used to treat infections worldwide. However, their inappropriate use has led to an increase in the incidence of drug-resistant bacteria and consequently, medical costs, at hospitals. To reduce inappropriate use and drug resistance, we have established a permission system to control the use of carbapenems at the Japanese Red Cross Nagoya Daiichi Hospital. In this study, we retrospectively evaluated the applicability of the new permission system compared to that of the notification system and the non control system for 14 months each. The two management systems were able to maintain total antibiotic use density and control the outbreak of drug-resistant bacteria (P. aeruginosa, E. coli, and K. pneumoniae). The number of carbapenem prescriptions was decreased dramatically when this permission system was enforced. Compared to the non control system, the cost of antimicrobials was reduced by $757,470 for the 14-month study period using the permission system. These results suggest that our system to control the use of antimicrobials can efficiently suppress the incidence of drug-resistant bacteria and medical costs at hospitals.

UR - http://www.scopus.com/inward/record.url?scp=84860649677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860649677&partnerID=8YFLogxK

M3 - Article

C2 - 22515115

AN - SCOPUS:84860649677

VL - 74

SP - 93

EP - 104

JO - Nagoya Journal of Medical Science

JF - Nagoya Journal of Medical Science

SN - 0027-7622

IS - 1-2

ER -